scholarly journals Validity of International Classification of Disease Codes to Identify Ischemic Stroke and Intracranial Hemorrhage Among Individuals With Associated Diagnosis of Atrial Fibrillation

2015 ◽  
Vol 8 (1) ◽  
pp. 8-14 ◽  
Author(s):  
Jonathan L. Thigpen ◽  
Chrisly Dillon ◽  
Kristen B. Forster ◽  
Lori Henault ◽  
Emily K. Quinn ◽  
...  
2021 ◽  
pp. 31-35
Author(s):  
V. G. Mishchuk ◽  
H. V. Kozinchuk ◽  
T. M. Miziuk ◽  
K. M. Skoropad ◽  
N. I. Turchyn

The International Classification of Functioning, Disability and Health (ICF) is gaining a special role. Using a set of clear definitions of functions, structure, activities and participation and environmental factors, the attending (family) doctor and rehabilitation doctor will be able to objectively assess the abilities and limitations of daily life and activities, consistently determining the factors influencing human functioning. The aim of the study: to assess the functionality, activity and participation of patients with arterial hypertension (AH) stage III, 2-3 degrees, severe risk according to the criteria of the ICF. Materials and methods: examined 53 patients with hypertension, 15 of whom had hypertensive crisis it was complicated by STEMI myocardial infarction (MI) with a rehabilitation diagnosis according to ICF s4100.378, b4200.8, 20 patients with hypertensive crisis complicated by ischemic stroke (rehabilitation diagnosis according to ICF - s110.878, b4200.8) and 18 patients with atrial fibrillation due to hypertensive crisis and a diagnosis of ICF - s4100.878, b4101.8. To assess the structural changes of the heart echocardiography. To assess activity and participation for all patients included in the study were offered and performed the Tinetti test (1986) with a separate assessment of balance and gait, using the Rivermead mobility index, a 6-minute walk test, and a modified Borg load perception scale. All obtained indicators were statistically processed. Results. Studies of myocardial structure show that its the largest mass was in patients with AH and atrial fibrillation and slightly lower, although insignificantly, in patients who developed a MI on the background of hypertensive crisis and significantly (p<0.05) less in the subjects, where hypertensive crisis was complicated by ischemic stroke. At the same time MMLV of all the patients significantly (p1,2,3<0,05) exceeded the similar indicator at healthy. The same nature of changes is characteristic of IMMLV in patients examined by us. The Tinnetti test for balance was the lowest (6.7±0.6 points) in patients with AH and hypertensive crisis complicated by ischemic stroke and 1.8 and 1.98 times higher (p1.3 <0.05) in patients with AH in whom the hypertensive crisis was complicated by MI and atrial fibrillation. The overall mobility of the subjects also depended on the nature of the complications of the hypertensive crisis and was most severely impaired in patients with ischemic stroke (6.3±0.5 points) and decreased 1.4 times (p<0.05) compared with patients with MI and 1.7 times in cases of complications of hypertensive crisis with cardiac arrhythmia. While performing the test with a 6-minute walk, it was found that patients with AH complicated by ischemic stroke, walked 133.3 m (p<0.01) shorter distance than those examined with AH complicated by MI. The Borg scale in patients with AH and hypertensive crisis, complicated by MI and ischemic stroke was almost the same and slightly exceeded its average degree. In cases of development after a hypertensive crisis of cardiac arrhythmias (atrial fibrillation), the Borg scale showed a slight fatigue. Thus, apart the biological model that takes into account the localization of the pathological process and its complications, a biosocial model is very important, which includes activity, participation, adaptation to everyday life and the environment, which has diverse changes and must be evaluated for rehabilitation planning in such patients.


Author(s):  
K. Neumann ◽  
B. Arnold ◽  
A. Baumann ◽  
C. Bohr ◽  
H. A. Euler ◽  
...  

Zusammenfassung Hintergrund Sprachtherapeutisch-linguistische Fachkreise empfehlen die Anpassung einer von einem internationalen Konsortium empfohlenen Änderung der Nomenklatur für Sprachstörungen im Kindesalter, insbesondere für Sprachentwicklungsstörungen (SES), auch für den deutschsprachigen Raum. Fragestellung Ist eine solche Änderung in der Terminologie aus ärztlicher und psychologischer Sicht sinnvoll? Material und Methode Kritische Abwägung der Argumente für und gegen eine Nomenklaturänderung aus medizinischer und psychologischer Sicht eines Fachgesellschaften- und Leitliniengremiums. Ergebnisse Die ICD-10-GM (Internationale statistische Klassifikation der Krankheiten und verwandter Gesundheitsprobleme, 10. Revision, German Modification) und eine S2k-Leitlinie unterteilen SES in umschriebene SES (USES) und SES assoziiert mit anderen Erkrankungen (Komorbiditäten). Die USES- wie auch die künftige SES-Definition der ICD-11 (International Classification of Diseases 11th Revision) fordern den Ausschluss von Sinnesbehinderungen, neurologischen Erkrankungen und einer bedeutsamen intellektuellen Einschränkung. Diese Definition erscheint weit genug, um leichtere nonverbale Einschränkungen einzuschließen, birgt nicht die Gefahr, Kindern Sprach- und weitere Therapien vorzuenthalten und erkennt das ICD(International Classification of Disease)-Kriterium, nach dem der Sprachentwicklungsstand eines Kindes bedeutsam unter der Altersnorm und unterhalb des seinem Intelligenzalter angemessenen Niveaus liegen soll, an. Die intendierte Ersetzung des Komorbiditäten-Begriffs durch verursachende Faktoren, Risikofaktoren und Begleiterscheinungen könnte die Unterlassung einer dezidierten medizinischen Differenzialdiagnostik bedeuten. Schlussfolgerungen Die vorgeschlagene Terminologie birgt die Gefahr, ätiologisch bedeutsame Klassifikationen und differenzialdiagnostische Grenzen zu verwischen und auf wertvolles ärztliches und psychologisches Fachwissen in Diagnostik und Therapie sprachlicher Störungen im Kindesalter zu verzichten.


BMC Neurology ◽  
2017 ◽  
Vol 17 (1) ◽  
Author(s):  
Hormuzdiyar H. Dasenbrock ◽  
David J. Cote ◽  
Yuri Pompeu ◽  
Viren S. Vasudeva ◽  
Timothy R. Smith ◽  
...  

Author(s):  
Mackenzie A Hamilton ◽  
Andrew Calzavara ◽  
Scott D Emerson ◽  
Jeffrey C Kwong

Objective: Routinely collected health administrative data can be used to efficiently assess disease burden in large populations, but it is important to evaluate the validity of these data. The objective of this study was to develop and validate International Classification of Disease 10PthP revision (ICD -10) algorithms that identify laboratory-confirmed influenza or laboratory-confirmed respiratory syncytial virus (RSV) hospitalizations using population-based health administrative data from Ontario, Canada. Study Design and Setting: Influenza and RSV laboratory data from the 2014-15 through to 2017-18 respiratory virus seasons were obtained from the Ontario Laboratories Information System (OLIS) and were linked to hospital discharge abstract data to generate influenza and RSV reference cohorts. These reference cohorts were used to assess the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of the ICD-10 algorithms. To minimize misclassification in future studies, we prioritized specificity and PPV in selecting top-performing algorithms. Results: 83,638 and 61,117 hospitalized patients were included in the influenza and RSV reference cohorts, respectively. The best influenza algorithm had a sensitivity of 73% (95% CI 72% to 74%), specificity of 99% (95% CI 99% to 99%), PPV of 94% (95% CI 94% to 95%), and NPV of 94% (95% CI 94% to 95%). The best RSV algorithm had a sensitivity of 69% (95% CI 68% to 70%), specificity of 99% (95% CI 99% to 99%), PPV of 91% (95% CI 90% to 91%) and NPV of 97% (95% CI 97% to 97%). Conclusion: We identified two highly specific algorithms that best ascertain patients hospitalized with influenza or RSV. These algorithms may be applied to hospitalized patients if data on laboratory tests are not available, and will thereby improve the power of future epidemiologic studies of influenza, RSV, and potentially other severe acute respiratory infections.


Circulation ◽  
2020 ◽  
Vol 142 (Suppl_4) ◽  
Author(s):  
Muhammad Khan ◽  
Muhammad U Khan ◽  
Muhammad Munir

Background: End stage renal disease (ESRD) is a well-recognized risk factor for development of sudden cardiac arrest(SCA). There is limited data on outcomes after an in-hospital SCA event in ESRD patients. Methods: Data were obtained from National Inpatient Sample from January 2007 to December 2017. In-hospital SCA was identified using International Classification of Disease, 9th Revision, Clinical Modification, and International Classification of Disease, 10th Revision, Clinical Modification codes of 99.60, 99.63, and 5A12012. ESRD patients were subsequently identified using codes of 585.6 and N18.6. Propensity -matched analysis using logistic regression with SD caliper of 0.2 was used to match patients with and without ESRD. Crude and propensity-matched (PS) cohorts outcomes were calculated. Results: A total of 1,412,985 patients sustained in-hospital SCA during our study period. ESRD patients with in-hospital SCA were younger and had a higher burden of key co-morbidities. Mortality was similar in ESRD and non-ESRD patients in PS matched cohort (70.4% vs. 70.7%, p = 0.45, figure 1) with an overall downward trend over our study years (figure 2). Conclusion: In the context of in-hospital SCA, mortality is similar in ESRD and non-ESRD patients in adjusted analysis. Adequate risk factor modification could further mitigate the risk of in-hospital SCA among ESRD patients


Author(s):  
Joris J Komen ◽  
Tomas Forslund ◽  
Aukje K Mantel-Teeuwisse ◽  
Olaf H Klungel ◽  
Mia von Euler ◽  
...  

Abstract Aims To analyze 90-day mortality in AF patients after a stroke or a severe bleed and assess associations with the type of antithrombotic treatment at the event. Methods and Results From the Stockholm Healthcare database, we selected 6 017 patients with a known history of AF who were diagnosed with ischemic stroke, 3 006 with intracranial hemorrhage, and 4 291 with a severe gastrointestinal bleed (GIB). The 90-day mortality rates were 25.1% after ischemic stroke, 31.6% after intracranial hemorrhage, and 16.2% after severe GIB. We used Cox regression and propensity score matched analyses to test the association between antithrombotic treatment at the event and 90-day mortality. After intracranial hemorrhage, there was a significantly higher mortality rate in warfarin compared to NOAC treated patients (adjusted hazard ratio (aHR): 1.36 CI: 1.04 – 1.78). After an ischemic stroke and a severe GIB, patients receiving antiplatelets or no antithrombotic treatment had significantly higher mortality rates compared to patients on NOACs, but there was no difference comparing warfarin to NOACs (aHR 0.84 CI: 0.63 – 1.12 after ischemic stroke, aHR 0.91 CI: 0.66 – 1.25 after severe GIB). Propensity score matched analysis yielded similar results. Conclusion Mortality rates were high in AF patients suffering from an ischemic stroke, an intracranial hemorrhage, or a severe GIB. NOAC treatment was associated with a lower 90 day mortality after intracranial hemorrhage than warfarin.


Sign in / Sign up

Export Citation Format

Share Document